Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR9) measure of suicidal risk.

IF 4.5 3区 医学 Q1 CLINICAL NEUROLOGY
Journal of Psychopharmacology Pub Date : 2024-09-01 Epub Date: 2024-08-08 DOI:10.1177/02698811241268875
Karabi Nandy, Rajesh Ranjan Nandy, A John Rush, Taryn L Mayes, Madhukar H Trivedi
{"title":"Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR<sub>9</sub>) measure of suicidal risk.","authors":"Karabi Nandy, Rajesh Ranjan Nandy, A John Rush, Taryn L Mayes, Madhukar H Trivedi","doi":"10.1177/02698811241268875","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR<sub>9</sub>) is a widely used patient-reported outcome measure of suicidal risk. The goal of this article is to provide an evidence-based interpretation of the CHRT-SR<sub>9</sub> total score in terms of four clinically actionable categories of suicidal risk (none, mild, moderate, and severe).</p><p><strong>Methods: </strong>Data from two large programs involving adolescents and adults were combined in this paper. In these studies, the CHRT-SR<sub>9</sub> was anchored against an independent measure of suicidal risk, the suicide item (Item #9) in the Patient Health Questionnaire (PHQ-9), with categories 0 (none), 1 (mild), 2 (moderate), and 3 (severe). In the combined data (<i>n</i> = 1945), we calculated the cumulative percentage of data across these four categories and the percentile score of the CHRT-SR<sub>9</sub> total score that corresponded to these percentages; from this, we developed ranges of the CHRT-SR<sub>9</sub> total score that corresponded to the four categories of Item #9 of PHQ-9. We also calculated similar ranges for two broad subscales of the CHRT-SR<sub>9</sub> total score; Propensity and Suicidal Thoughts. To assess the robustness of our findings, we repeated the analysis at another timepoint across studies.</p><p><strong>Results: </strong>Findings indicated that the CHRT-SR<sub>9</sub> total score (range: 0-36) can be categorized as none (0-14), mild (15-21), moderate (22-26), and severe (27-36). Similar categories were calculated for the Propensity and Suicidal Thoughts subscales. The findings were the same when repeated at another timepoint.</p><p><strong>Conclusion: </strong>This categorization of the CHRT-SR<sub>9</sub> total score can place patients into clinically meaningful and actionable categories of suicidal risk.</p>","PeriodicalId":16892,"journal":{"name":"Journal of Psychopharmacology","volume":" ","pages":"784-788"},"PeriodicalIF":4.5000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457466/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02698811241268875","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR9) is a widely used patient-reported outcome measure of suicidal risk. The goal of this article is to provide an evidence-based interpretation of the CHRT-SR9 total score in terms of four clinically actionable categories of suicidal risk (none, mild, moderate, and severe).

Methods: Data from two large programs involving adolescents and adults were combined in this paper. In these studies, the CHRT-SR9 was anchored against an independent measure of suicidal risk, the suicide item (Item #9) in the Patient Health Questionnaire (PHQ-9), with categories 0 (none), 1 (mild), 2 (moderate), and 3 (severe). In the combined data (n = 1945), we calculated the cumulative percentage of data across these four categories and the percentile score of the CHRT-SR9 total score that corresponded to these percentages; from this, we developed ranges of the CHRT-SR9 total score that corresponded to the four categories of Item #9 of PHQ-9. We also calculated similar ranges for two broad subscales of the CHRT-SR9 total score; Propensity and Suicidal Thoughts. To assess the robustness of our findings, we repeated the analysis at another timepoint across studies.

Results: Findings indicated that the CHRT-SR9 total score (range: 0-36) can be categorized as none (0-14), mild (15-21), moderate (22-26), and severe (27-36). Similar categories were calculated for the Propensity and Suicidal Thoughts subscales. The findings were the same when repeated at another timepoint.

Conclusion: This categorization of the CHRT-SR9 total score can place patients into clinically meaningful and actionable categories of suicidal risk.

基于证据的 9 项简明健康风险追踪--自我报告(CHRT-SR9)自杀风险测量解释指南。
背景:9项简明健康风险追踪-自我报告(CHRT-SR9)是一种广泛使用的患者报告的自杀风险结果测量方法。本文的目的是根据自杀风险的四个临床可操作类别(无、轻度、中度和重度)对 CHRT-SR9 总分进行循证解释:本文综合了两个涉及青少年和成年人的大型项目的数据。在这些研究中,CHRT-SR9 被锚定在一个独立的自杀风险测量指标上,即患者健康问卷(PHQ-9)中的自杀项目(第 9 项),类别为 0(无)、1(轻度)、2(中度)和 3(重度)。在合并数据(n = 1945)中,我们计算了这四个类别数据的累计百分比以及与这些百分比相对应的 CHRT-SR9 总分百分位数;由此,我们得出了与 PHQ-9 第 9 项四个类别相对应的 CHRT-SR9 总分范围。我们还为 CHRT-SR9 总分的两个大的分量表(倾向和自杀想法)计算了类似的范围。为了评估研究结果的稳健性,我们在不同研究的另一个时间点重复进行了分析:研究结果表明,CHRT-SR9 总分(范围:0-36)可分为无(0-14)、轻度(15-21)、中度(22-26)和重度(27-36)。倾向分量表和自杀想法分量表也计算了类似的类别。结论:结论:CHRT-SR9 总分的这种分类方法可以将患者划分为具有临床意义和可操作的自杀风险类别。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Psychopharmacology
Journal of Psychopharmacology 医学-精神病学
CiteScore
8.60
自引率
4.90%
发文量
126
审稿时长
3-8 weeks
期刊介绍: The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects. The Journal of Psychopharmacology is truly international in scope and readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信